195 related articles for article (PubMed ID: 38663961)
1. Exploring TLR signaling pathways as promising targets in cervical cancer: The road less traveled.
Agarwal M; Kumar M; Pathak R; Bala K; Kumar A
Int Rev Cell Mol Biol; 2024; 385():227-261. PubMed ID: 38663961
[TBL] [Abstract][Full Text] [Related]
2. Targeting Toll like Receptors in Cancer: Role of TLR Natural and Synthetic Modulators.
Narayanankutty A; Sasidharan A; Job JT
Curr Pharm Des; 2020; 26(39):5040-5053. PubMed ID: 32693759
[TBL] [Abstract][Full Text] [Related]
3. Toll-Like Receptor Signaling and Its Inducible Proteins.
Satoh T; Akira S
Microbiol Spectr; 2016 Dec; 4(6):. PubMed ID: 28084212
[TBL] [Abstract][Full Text] [Related]
4. The Yin and Yang of Toll-like receptors in cancer.
Pradere JP; Dapito DH; Schwabe RF
Oncogene; 2014 Jul; 33(27):3485-95. PubMed ID: 23934186
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy.
Li TT; Ogino S; Qian ZR
World J Gastroenterol; 2014 Dec; 20(47):17699-708. PubMed ID: 25548469
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptors: Triggers of regulated cell death and promising targets for cancer therapy.
Yang Y; Feng R; Wang YZ; Sun HW; Zou QM; Li HB
Immunol Lett; 2020 Jul; 223():1-9. PubMed ID: 32311408
[TBL] [Abstract][Full Text] [Related]
7. Pathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells.
Tartey S; Takeuchi O
Int Rev Immunol; 2017 Mar; 36(2):57-73. PubMed ID: 28060562
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Toll-like receptor transcriptome in squamous cell carcinoma of cervix: A case-control study.
Aggarwal R; Misra S; Guleria C; Suri V; Mangat N; Sharma M; Nijhawan R; Minz R
Gynecol Oncol; 2015 Aug; 138(2):358-62. PubMed ID: 26024767
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus 16 infection alters the Toll-like receptors and downstream signaling cascade: A plausible early event in cervical squamous cell carcinoma development.
Guleria C; Suri V; Kapoor R; Minz RW; Aggarwal R
Gynecol Oncol; 2019 Oct; 155(1):151-160. PubMed ID: 31375269
[TBL] [Abstract][Full Text] [Related]
10. Decoding Toll-like receptors: Recent insights and perspectives in innate immunity.
Kawai T; Ikegawa M; Ori D; Akira S
Immunity; 2024 Apr; 57(4):649-673. PubMed ID: 38599164
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptors in human papillomavirus infection.
Zhou Q; Zhu K; Cheng H
Arch Immunol Ther Exp (Warsz); 2013 Jun; 61(3):203-15. PubMed ID: 23435874
[TBL] [Abstract][Full Text] [Related]
12. Regulation of toll-like receptor (TLR) signaling pathways in atherosclerosis: from mechanisms to targeted therapeutics.
Jin M; Fang J; Wang JJ; Shao X; Xu SW; Liu PQ; Ye WC; Liu ZP
Acta Pharmacol Sin; 2023 Dec; 44(12):2358-2375. PubMed ID: 37550526
[TBL] [Abstract][Full Text] [Related]
13. Expressions of Toll-like receptors 3, 4, 7, and 9 in cervical lesions and their correlation with HPV16 infection in Uighur women.
Hasimu A; Ge L; Li QZ; Zhang RP; Guo X
Chin J Cancer; 2011 May; 30(5):344-50. PubMed ID: 21527067
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptors in hepatocellular carcinoma: potential novel targets for pharmacological intervention.
Zou H; Wang WK; Liu YL; Braddock M; Zheng MH; Huang DS
Expert Opin Ther Targets; 2016 Sep; 20(9):1127-35. PubMed ID: 26998881
[TBL] [Abstract][Full Text] [Related]
15. Toll-Like Receptors (TLRs) in the Tumor Microenvironment (TME): A Dragon-Like Weapon in a Non-fantasy Game of Thrones.
Angrini M; Varthaman A; Cremer I
Adv Exp Med Biol; 2020; 1263():145-173. PubMed ID: 32588327
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptors.
Takeda K; Akira S
Curr Protoc Immunol; 2015 Apr; 109():14.12.1-14.12.10. PubMed ID: 25845562
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the Toll-Like Receptor/Nitric Oxide Signaling Pathway in the Pathogenesis of Cervical Cancer Caused by High-Risk Human Papillomavirus Infection.
Li J; Rao H; Jin C; Liu J
Biomed Res Int; 2017; 2017():7830262. PubMed ID: 28626766
[TBL] [Abstract][Full Text] [Related]
18. Important aspects of Toll-like receptors, ligands and their signaling pathways.
Chang ZL
Inflamm Res; 2010 Oct; 59(10):791-808. PubMed ID: 20593217
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptors as targets for immune disorders.
Keogh B; Parker AE
Trends Pharmacol Sci; 2011 Jul; 32(7):435-42. PubMed ID: 21529972
[TBL] [Abstract][Full Text] [Related]
20. How location governs toll-like receptor signaling.
Chaturvedi A; Pierce SK
Traffic; 2009 Jun; 10(6):621-8. PubMed ID: 19302269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
